All systems go for AFT Pharmaceuticals

All systems go for AFT Pharmaceuticals
Hartley Atkinson: negative economy won't impact growth. (Image: Supplied)
Brent Melville
AFT Pharmaceuticals expects to make inroads into the Australian market on the strength of its new Maxigesic sinus and pain treatment and hot drink sachet products.Product sales in Australia have steadily improved after the listed pharmaceutical group's successful legal appeal against British-based consumer products giant Reckitt Benckiser, allowing AFT to compare its products with paracetamol and ibuprofen in its advertising.That helped push overall product sales and royalties up by 30% during the half year to September 2022, though first-h...

More Markets

Trade Me parent company appoints Owen Wilson as director
Finance

Trade Me parent company appoints Owen Wilson as director

Wilson was CE of $A30b Australian digital-property company Rea Group Ltd.

Me Today’s $2.2m capital raise ‘exceeds expectations’
Markets

Me Today’s $2.2m capital raise ‘exceeds expectations’

The company’s two largest shareholders chipped in $1.5m.

Being AI’s bold plan: No business, still listed
Markets

Being AI’s bold plan: No business, still listed

From wannabe Google challenger to now selling off its last business to escape debt.

Westpac NZ eyes improved full-year 2026 profit on GDP gains
Finance

Westpac NZ eyes improved full-year 2026 profit on GDP gains

Looks to grow at pace of economy, invests in business.